Journal ArticleOPEN ACCESS

Promise of cancer stem cell vaccine

Human Vaccines and Immunotherapeutics (2015) 11(12) 2796-2799
DOI: 10.1080/21645515.2015.1083661
16Citations
Citations of this article
42Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Dendritic cell (DC)-based vaccines designed to target cancer stem cells (CSC) can induce significant antitumor responses via conferring host anti-CSC immunity. Our recent studies have demonstrated that CSC-DC vaccine could inhibit metastasis of primary tumors and induce humoral immune responses against cancer stem cells. This approach highlights the promise of cancer stem cell vaccine in cancer immunotherapy.

Author supplied keywords

Cite

CITATION STYLE

APA

Zhou, L., Lu, L., Wicha, M. S., Chang, A. E., Xia, J. chuan, Ren, X., & Li, Q. (2015). Promise of cancer stem cell vaccine. Human Vaccines and Immunotherapeutics, 11(12), 2796–2799. https://doi.org/10.1080/21645515.2015.1083661

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free